Note 4. Segment Information

We determined our reportable segments under the provisions of U.S. GAAP related to disclosures about segments of an enterprise. Management has concluded that Mobile Solutions, Power Solutions, and Life Sciences each constitutes an operating segment as each engages in business activities for which it earns revenues and incurs expenses for which separate financial information is available, and this is the level at which the Chief Operating Decision Maker (“CODM”) reviews discrete financial information for purposes of allocating resources and assessing performance. In making this determination, management considered the form and content of the financial information that is regularly reviewed by the CODM. As described in Note 1, in January 2018, we implemented a new enterprise and management structure and reorganized our businesses into the Mobile Solutions, Power Solutions and Life Sciences divisions based principally on the end markets they serve. In the first quarter of 2018, we began reporting our financial results based on these new reportable segments. Prior year amounts have been restated to conform to the current year presentation.

Mobile Solutions

Our Mobile Solutions division is focused on growth in the industrial and automotive end markets. Within this division we manufacture highly engineered, difficult-to-manufacture precision metal components and subassemblies for the automotive and general industrial end markets.

We sell a wide range of highly engineered, extremely close tolerance, precision-machined metal components and subassemblies primarily to the automotive and general industrial end markets. We have developed an expertise in manufacturing highly complex, system critical components for fuel systems, engines and transmissions, power steering systems and electromechanical motors on a high-volume basis. This expertise has been gained through investment in technical capabilities, processes and systems, and skilled program management and product launch capabilities.

Power Solutions

Our Power Solutions division is focused on growth in the electrical, and aerospace and defense end markets. Within this division we combine materials science expertise with advanced engineering and production capabilities to design and manufacture a broad range of high-precision metal and plastic components, assemblies and finished devices used in applications ranging from power control to flight control and for military devices.

We manufacture a variety of products including electrical contacts, connectors, contact assemblies and precision stampings for the electrical end market and high precision products for the aerospace and defense end markets utilizing our extensive process technologies for optical grade plastics, thermally conductive plastics, titanium, Inconel, magnesium and electroplating.

Life Sciences

Our Life Sciences division is focused on growth in the medical end market. Within this division we combine advanced engineering and production capabilities to design and manufacture a broad range of high-precision metal and plastic components, assemblies and finished devices.

We manufacture a variety of components, assemblies and instruments, such as surgical knives, bioresorbable implants, surgical staples, orthopedic system tools, laparoscopic devices, and drug delivery devices for the medical and life sciences end market.

Segment Results

The following table presents results of continuing operations for each reportable segment.


	Mobile Solutions		Power Solutions		Life Sciences		Corporate and Consolidations			Total Continuing Operations
Three Months Ended March 31, 2018
Net sales	$	89,794	$	48,682	$	31,200	$	(528	) (a)	$	169,148
Income (loss) from operations	$	9,785	$	5,233	$	4,204	$	(15,529	)	$	3,693
Interest expense											(11,996	)
Other income, net											313

Loss from continuing operations before benefit for income taxes and share of net income from joint venture										$	(7,990	)

Three Months Ended March 31, 2017
Net sales	$	86,446	$	48,424	$	23,129	$	(444	)	$	157,555
Income (loss) from operations	$	10,601	$	6,795	$	3,622	$	(7,166	)	$	13,852
Interest expense											(14,839	)
Other											810

Loss from continuing operations before benefit for income taxes and share of net income from joint venture										$	(177	)

(a)	Includes eliminations of intersegment transactions occurring during the ordinary course of business.


	Total Assets as of
	March 31, 2018		December 31, 2017
Mobile Solutions	$	453,521	$	428,321
Power Solutions		393,048		383,063
Life Sciences		362,744		355,703
Corporate and Consolidations		275,769		307,916

Total Continuing Operations	$	1,485,082	$	1,475,003

The Bridgemedica business acquired on February 22, 2018, contributed $1.3 million to net sales and $0.1 million to income from operations in the Life Sciences division after the acquisition date through March 31, 2018.